Antiplatelet antithrombotic therapy unstable angina well-controlled clinical trials incidence coronary events unstable angina benefits present acute subacute chronic phases disease independent doses protocol differences benefit aspirin antiplatelet drugs clinical trials heparin added substantial benefit management unstable angina event rate incidence refractory angina long-term benefit antithrombin therapy successes failure rate aspirin heparin high search potent safe antiplatelet antithrombotic drugs 